Cost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer
Authors:
- 15 October 2009
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 21 (5) , 1072-1077
Abstract
Background: Patients with node-positive head and neck squamous cell carcinomas (HNC) have a significant risk of residual disease (RD) in the neck after treatment, despite optimal chemoradiotherapy (CRT). Adjuvant neck dissection (ND) after CRT has been considered standard treatment, but its morbidity has led investigators to consider using post-CRT imaging to determine the need for surgery. We analyzed the cost-effectiveness of computed tomography (CT) and positron emission tomography–computed tomography (PET-CT) as predictors of the need for ND compared with ND for all patients. Materials and methods: We developed a Markov model to describe health states in the 5 years after CRT for HNC in a 50-year-old man. We compared three strategies: dissect all patients, dissect patients with RD on CT, and dissect patients with RD on PET-CT. Probabilistic sensitivity analyses were carried out to model uncertainty in PET-CT performance, up-front and salvage dissection costs, and patient utilities. Results: ND only for patients with RD on PET-CT was the dominant strategy over a wide range of realistic and exaggerated assumptions. Probabilistic sensitivity analyses confirmed that the PET-CT strategy was almost certainly cost-effective at a societal willingness-to-pay threshold of $500 000/quality-adjusted life year. Conclusion: Adjuvant ND reserved for patients with RD on PET-CT is the dominant and cost-effective strategy.Keywords
This publication has 27 references indexed in Scilit:
- The role of CT and18F-FDG PET in managing the neck in node-positive head and neck cancer after chemoradiotherapyActa Oto-Laryngologica, 2009
- A pragmatic randomised controlled trial of the cost-effectiveness of palliative therapies for patients with inoperable oesophageal cancerHealth Technology Assessment, 2005
- Assessment of Health State Utilities and Quality of Life in Patients With Malignant Esophageal DysphagiaAmerican Journal of Gastroenterology, 2004
- Who merits a neck dissection after definitive chemoradiotherapy for N2–N3 squamous cell head and neck cancer?Head & Neck, 2003
- Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- The cost-effectiveness of fluorodeoxyglucose 18-F positron emission tomography in the N0 neckCancer, 2001
- Whole-Body PET Imaging With [18F]Fluorodeoxyglucose in Management of Recurrent Colorectal CancerArchives of Surgery, 1999
- Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancerHead & Neck, 1997
- Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrenceCancer, 1995
- Markov Models in Medical Decision MakingMedical Decision Making, 1993